Navigation Links
Planning to Avoid the Next Super Storm: A Road Map for Protecting Your Business Operations & Supply Chain

CHAPEL HILL, N.C., Nov. 9, 2012 /PRNewswire/ -- In the wake of recent catastrophic events such as Hurricane Sandy, pharmaceutical and medical device companies are becoming more aware of the need to safeguard their competitiveness levels by executing strategic plans that include consistent monitoring and evaluation of emergency measures.

Unfortunately, the occurrence of a natural disaster is typically when most companies begin to regret not having a business continuity system in place. To identify how other world-class companies plan, prevent, prepare and respond to potential threats, Best Practices, LLC has published a new study: "Best Practices in Crisis Management & Business Continuity for BioPharma Manufacturing and Supply Chain Operations."

Key Insights Include:

  • System fortification and redundant resources were seen to be the most effective means of avoiding outages and failures.
  • Sole-source suppliers may provide the lowest price – but they also may endanger the supply chain.
  • More than half of companies require suppliers have facilities in different regions to further hedge against disruption risk.
  • Two thirds of companies employ various simulations, war games and scenario plans at least once a year to challenge business continuity plans and preparations.

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link:

While building up capacities for emergency responses continues to be a priority, the severity and frequency of disasters in the last decade reinforces the need to place much greater attention to the implementation of proactive strategies that ensure the continuity of supply chain and manufacturing functions. Achieving growth and sustainability is not just a matter of sustaining proven business models, but also of being prepared for unplanned events that can disrupt the effectiveness of such models.

The 110-page report contains over 500 metrics and 55 narratives that provide empirical evidence from leading biopharmaceutical companies on how to promptly and efficiently reduce the risks from and respond to emergencies to prevent or minimize the costs of emergency events.

For more information on this study or other recent primary research studies, contact us at 919.403.0251 or at

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. A Successful Launch of a New Oncology Product Requires Global Teams & Planning
2. Elekta Launches New Version of Monaco Treatment Planning System with Segment Shape Optimization
3. Cipla Medpro Achieves "Worry Free" Supply Chain Planning with Help from ToolsGroup
4. GE Healthcare Imaging Equipment now available in Attainias Equipment Planning System
5. Report Highlights Key Activities that Drive Successful New Product Planning Groups in Pharmaceutical Industry
6. Medical Affairs Plays Important Role in the Success of New Product Planning Programs
7. Helping Start-Ups Avoid Slow-Downs
8. Stater Bros. Super Rx Pharmacies To Offer Free Antibiotics
9. Amarantus BioSciences Announces MANF Demonstrates Superiority over GDNF in Neurorestoration Behavioural Animal Model of Parkinsons Disease
10. arGEN-X Appoints Dr. David L. Lacey to its Supervisory Board
11. Silicon Nitride Demonstrates Statistical Superior Osteointegration and Anti-infective Biomaterial Properties
Post Your Comments:
(Date:11/30/2015)... 30, 2015 iCAD, Inc. (Nasdaq: ... its latest solutions for advanced image analysis and ... at the Radiological Society of North American (RSNA) ... from November 29 to December 4, 2015. ... iReveal®, an automated breast density assessment solution, PowerLook® ...
(Date:11/30/2015)... 30, 2015 Booth #4303 – The Imaging Components ... exhibit a broader array of products in a new booth ... North America in Chicago ... will feature X-ray components "At the Heart of Imaging." Products ... products from Varian,s Claymount brand, and computer-aided diagnostic software from ...
(Date:11/30/2015)... , Nov. 30, 2015  Novartis will demonstrate ... the 57 th American Society of Hematology (ASH) ... and myelomas as well as supportive care, including key ... to personalized cell therapies. The ASH Annual Meeting will ... . Novartis Oncology . "We will ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... ... anxiety, illness, infection or even a need for eyeglasses can sometimes cause headaches, but ... pediatric neurosurgeon at Joe DiMaggio Children’s Hospital in Hollywood, Florida, said that while headaches ... headaches that don’t go away, that don’t have any other reason, even after you’ve ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... driverless vehicle experience this summer, ushering in a new era of publicly accessible ... and electric shuttle, will continue to offer guests an up-close look at the ...
(Date:11/30/2015)... ... 30, 2015 , ... The presidential race normally deals with political issues of ... a national news story when Donald Trump makes disparaging remarks about Hillary Clinton’s hairstyle? ... than anyone wants to admit when it comes to how people are viewed by ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... Catalyst continuing education course in Dallas, TX, on January 29 and 30, 2016. ... to improve the functions of their practices, to learn how to better succeed ...
(Date:11/30/2015)... ... November 30, 2015 , ... A ... of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of ... Their study showed that small molecule analogs that target the functions of SecA, ...
Breaking Medicine News(10 mins):